Using Silvercel® Non-Adherent: Case Studies 2012
This document contains a series of case reports describing the use of SILVERCEL® NON-ADHERENT (Systagenix) in patients with a range of wound types. All patients were treated for a minimum of four weeks and the decision to continue with SILVERCEL® NON-ADHERENT was based on continual assessment. A formal assessment was performed weekly, although in some cases dressing changes were carried out more frequently.
All patients were assessed for:
- clinical signs of infection/critical colonisation
- pain prior to and during dressing changes using a visual analogue scale of 1-10, where 1 = no pain and 10 = worst possible pain (see below)
- signs of improvement, including granulation extent and reduction in wound size.
Photographs were taken weekly in the majority of cases to document wound progression. Relevant additional wound treatments, eg compression therapy, antibiotic therapy, analgesia, etc were reported.
The clinicians undertaking the study were also asked to rate the dressing (from highly satisfied to dissatisfied) and to record whether the dressing needed soaking prior to removal and/or the dressing left any debris in the wound.
In addition, clinicians were offered the opportunity to check the protease activity in the wound using WOUNDCHEK™ Protease Status test (Systagenix).
The weekly assessment outcomes are cited for each case where:
↓ = reduction ↑ = increase - = no change or not present
This document has been jointly developed by Wounds International and Systagenix with financial support from Systagenix